Snapshot from Jun 25, 2026 at 22:38 UTC. For live data and tracking: View Live
Entities / People / David Kenley
Person

David Kenley

Tracked across 1 events · 10 articles · First seen Jun 11, 2026 · Last active Jun 12, 2026

Sentiment
0
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 0
Tech
Lateral Pharma identifies neuropathic pain target
Lateral Pharma announced the publication of peer-reviewed research in PAIN (journal), identifying Lanthionine Synthetase C-Like Protein 1 (LanCL1) as a novel therapeutic target for neuropathic pain. This research demonstrates that Lateral Pharma's Stressed Cell Protectant…
Impact: David Kenley, CEO of Lateral Pharma, highlighted the significance of the publication as a pivotal milestone for advancing neuropathic pain biology and accelerating Lateral Pharma's mission.
Jun 11, 2026 · 10 articles
NEWSDESK
Track David Kenley live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.